Bristol-Myers Squibb Company
Ticker
BMY
ISIN
US1101221083
Price
USD 58.85
Change Today
+0.44 / 0.753 %
Price 1 year ago
48.17 / 22.161 %
Market Capitalization
170,534,944,768.00
52 Week Low
39.02
52 Week High
59.82
200 Day Moving Average
47.33
50-day Moving Average
52.37
Price evolution
Yearly Returns
Peers
Peers
Company information
Summary
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
Sector
Healthcare
Industry
Drug Manufacturers—General
Country
United States
Exchange
NYQ
Earnings Per Share
-2.764
P/E Ratio
-
Debt/Equity Ratio
131.812
Beta
0.442315
Ebitda
21,134,999,552.00
Ebitda Margins
0.45
Enterprise to Ebitda
8.87
Enterprise Value
187,385,118,720.00
Target Price
81.38
Estimated Price
23.56
Book Value
16.84
Expected Growth
-
Balance sheet
Income statement
Sustainability
Correlation
| Company | Name | Correlation |
|---|---|---|
| 600436.SS | ZHANGZHOU PIENTZEHUANG PHARMACE | -0.32 |
| 4568.T | DAIICHI SANKYO COMPANY LIMITED | -0.05 |
| KLBF.JK | Kalbe Farma Tbk. | -0.04 |
| 600276.SS | JIANGSU HENGRUI MEDICAL CO LTD | -0.02 |
| 600867.SS | TONGHUA DONGBAO MEDICINES CO LT | -0.00 |
| 2186.HK | LUYE PHARMA | 0.07 |
| ECILC.IS | ECZACIBASI ILAC | 0.15 |
| MYX.AX | M PHARMA FPO | 0.15 |
| PFE | Pfizer, Inc. | 0.20 |
| 4503.T | ASTELLAS PHARMA | 0.23 |
| GILD | Gilead Sciences, Inc. | 0.24 |
| 300006.SZ | CHONGQING LUMMY PH | 0.26 |
| HZNP | Horizon Therapeutics Public Lim | 0.27 |
| 600771.SS | GUANGYUYUAN CHINESE HERBAL MEDI | 0.29 |
| 600713.SS | NANJING PHARMACEUTICAL CO LTD | 0.30 |
| 600613.SS | SHANGHAI SHENQI PHARM INVEST MA | 0.30 |
| 600572.SS | ZHEJIANG CONBA PHARMACEUTICAL C | 0.39 |
| 1093.HK | CSPC PHARMA | 0.40 |
| AZN | Astrazeneca PLC | 0.44 |
| LLY | Eli Lilly and Company | 0.49 |
| 4519.T | CHUGAI PHARMACEUTICAL CO | 0.51 |
| GSK.L | GSK PLC | 0.54 |
| SNY | Sanofi | 0.56 |
| MRK | Merck & Company, Inc. | 0.59 |
| AMGN | Amgen Inc. | 0.60 |
| GSK | GSK plc | 0.60 |
| ABBV | AbbVie Inc. | 0.65 |
| JNJ | Johnson & Johnson | 0.69 |
| NOVN.SW | NOVARTIS N | 0.70 |
Similar companies
| Ticker | Name | City | Country | Currency | Exchange | Beta | EV/EBITDA | Employees | Site |
|---|---|---|---|---|---|---|---|---|---|
| 600276.SS | JIANGSU HENGRUI MEDICAL CO LTD | Lianyungang | China | CNY | SHH | 58.73 | 24491 | https://www.hrs.com.cn | |
| KLBF.JK | Kalbe Farma Tbk. | Jakarta | Indonesia | IDR | JKT | 0.50 | 14.50 | 12392 | https://www.kalbe.co.id |
| 1093.HK | CSPC PHARMA | Shijiazhuang | China | HKD | HKG | 0.67 | 12.86 | 24746 | https://www.cspc.com.hk |
| 300006.SZ | CHONGQING LUMMY PH | Chongqing | China | CNY | SHZ | 0.83 | -32.33 | 935 | https://www.cqlummy.com |
| PFE | Pfizer, Inc. | New York | United States | USD | NYQ | 0.68 | 6.88 | 79000 | https://www.pfizer.com |
| 600572.SS | ZHEJIANG CONBA PHARMACEUTICAL C | Hangzhou | China | CNY | SHH | 0.46 | 10.69 | 8589 | https://www.conbagroup.com |
| 600713.SS | NANJING PHARMACEUTICAL CO LTD | Nanjing | China | CNY | SHH | 0.46 | 9.37 | 5062 | https://www.njyy.com |
| 600867.SS | TONGHUA DONGBAO MEDICINES CO LT | Tonghua | China | CNY | SHH | 0.24 | 12.42 | https://www.thdb.com | |
| ECILC.IS | ECZACIBASI ILAC | Istanbul | Turkey | TRY | IST | 0.20 | 71.70 | 336 | https://www.eczacibasi.com.tr/en/eczacibasi-gruop/companies/other-products-and-services |
| GSK.L | GSK PLC | Brentford | United Kingdom | GBp | LSE | 0.32 | 6.22 | 90096 | https://www.gsk.com |
| MRK | Merck & Company, Inc. | Kenilworth | United States | USD | NYQ | 0.36 | 10.37 | 67000 | https://www.merck.com |
| BMY | Bristol-Myers Squibb Company | New York | United States | USD | NYQ | 0.44 | 8.87 | 32200 | https://www.bms.com |
| 600771.SS | GUANGYUYUAN CHINESE HERBAL MEDI | Xi'an | China | CNY | SHH | 0.55 | -48.11 | 1900 | https://www.guangyuyuan.com |
| GILD | Gilead Sciences, Inc. | Foster City | United States | USD | NMS | 0.39 | 7.19 | 14400 | https://www.gilead.com |
| JNJ | Johnson & Johnson | New Brunswick | United States | USD | NYQ | 0.57 | 14.45 | 141700 | https://www.jnj.com |
| GSK | GSK plc | Brentford | United Kingdom | USD | NYQ | 0.18 | 8.08 | 90096 | https://www.gsk.com |
| AZN | Astrazeneca PLC | Cambridge | United Kingdom | USD | NMS | 0.12 | 18.55 | 83100 | https://www.astrazeneca.com |
| ABBV | AbbVie Inc. | North Chicago | United States | USD | NYQ | 0.75 | 11.46 | 50000 | https://www.abbvie.com |
| 2186.HK | LUYE PHARMA | Yantai | China | HKD | HKG | 0.75 | 14.06 | 4845 | https://www.luye.cn |
| 600613.SS | SHANGHAI SHENQI PHARM INVEST MA | Shanghai | China | CNY | SHH | 0.36 | 22.96 | 1371 | https://www.gzsq.com |
| MYX.AX | M PHARMA FPO | Salisbury South | Australia | AUD | ASX | 1.09 | 27.98 | https://www.maynepharma.com | |
| 4568.T | DAIICHI SANKYO COMPANY LIMITED | Tokyo | Japan | JPY | JPX | 52.12 | 16458 | https://www.daiichisankyo.com | |
| 4503.T | ASTELLAS PHARMA | Tokyo | Japan | JPY | JPX | 0.58 | 12.39 | 14522 | https://www.astellas.com |
| NOVN.SW | NOVARTIS N | Basel | Switzerland | CHF | EBS | 0.50 | 10.30 | 108000 | https://www.novartis.com |
| SNY | Sanofi | Paris | France | USD | NMS | 0.36 | 9.75 | 95442 | https://www.sanofi.com |
| HZNP | Horizon Therapeutics Public Lim | Dublin | Ireland | USD | NMS | 1.16 | 20.67 | 1940 | https://www.horizontherapeutics.com |
| LLY | Eli Lilly and Company | Indianapolis | United States | USD | NYQ | 0.37 | 29.00 | 35000 | https://www.lilly.com |
| AMGN | Amgen Inc. | Thousand Oaks | United States | USD | NMS | 0.58 | 12.61 | 24200 | https://www.amgen.com |
| 4519.T | CHUGAI PHARMACEUTICAL CO | Tokyo | Japan | JPY | JPX | 0.64 | 9.60 | 7664 | https://www.chugai-pharm.co.jp |
| 600436.SS | ZHANGZHOU PIENTZEHUANG PHARMACE | Zhangzhou | China | CNY | SHH | 0.78 | 57.53 | 2591 | https://www.zzpzh.com.cn |
| BAYN.DE | BAYER AG | Leverkusen | Germany | EUR | GER | 1.16 | 13.66 | 101914 | https://www.bayer.com |
| AZN.L | ASTRAZENECA PLC ORD SHS $0.25 | Cambridge | United Kingdom | GBp | LSE | 0.10 | 15.96 | 83100 | https://www.astrazeneca.com |
| 300357.SZ | ZHEJIANG WOLWO BIO | Huzhou | China | CNY | SHZ | 0.40 | 56.57 | 1488 | https://www.wolwobiotech.com |
| SAN.PA | SANOFI | Paris | France | EUR | PAR | 0.36 | 9.86 | 95442 | https://www.sanofi.com |
| NVS | Novartis AG | Basel | Switzerland | USD | NYQ | 0.49 | 10.62 | 108000 | https://www.novartis.com |
| 0P6S.IL | BAYER AG | Leverkusen | Germany | EUR | IOB | 1.15 | 9.51 | 100753 | https://www.bayer.com |
| CIPLA.NS | CIPLA LTD | Mumbai | India | INR | NSI | 17.91 | https://www.cipla.com | ||
| 4528.T | ONO PHARMACEUTICAL CO | Osaka | Japan | JPY | JPX | 0.33 | 13.40 | 3687 | https://www.ono-pharma.com |
| 4536.T | SANTEN PHARMACEUTICAL CO | Osaka | Japan | JPY | JPX | 0.37 | 7.05 | 4315 | https://www.santen.com |
| OGN | Organon & Co. | Jersey City | United States | USD | NYQ | 7.83 | 9300 | https://www.organon.com |
Funds
Mutual Fund Holders
Social
Dividends
Ratings
News
Earnings
SEC Filings
Options
Indicators
Glossary
- Momentum
- A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
- Inertia
- In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
- Relative Strength Index (RSI)
- A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
- Fibonacci's Weighted Moving Average
- A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
- Williams %R
- A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
- Relative Volatility Index (RVI)
- A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
- Commodity Channel Index (CCI)
- A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.